| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.31e-05 | 599 | 58 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 7.03e-05 | 76 | 58 | 4 | GO:0098631 | |
| GeneOntologyMolecularFunction | cadherin binding | 4.41e-04 | 339 | 58 | 6 | GO:0045296 | |
| GeneOntologyCellularComponent | nuclear envelope | 1.31e-04 | 560 | 57 | 8 | GO:0005635 | |
| GeneOntologyCellularComponent | nuclear pore | 1.67e-04 | 101 | 57 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | cuticular plate | 5.59e-04 | 13 | 57 | 2 | GO:0032437 | |
| GeneOntologyCellularComponent | annulate lamellae | 6.51e-04 | 14 | 57 | 2 | GO:0005642 | |
| Domain | FOXO_KIX-bd | 8.51e-06 | 2 | 55 | 2 | IPR032068 | |
| Domain | FOXO_KIX_bdg | 8.51e-06 | 2 | 55 | 2 | PF16675 | |
| Domain | FOXO-TAD | 2.55e-05 | 3 | 55 | 2 | IPR032067 | |
| Domain | FOXO-TAD | 2.55e-05 | 3 | 55 | 2 | PF16676 | |
| Domain | Grip | 4.60e-04 | 11 | 55 | 2 | SM00755 | |
| Domain | GRIP | 4.60e-04 | 11 | 55 | 2 | PF01465 | |
| Domain | Ran_BP1 | 5.51e-04 | 12 | 55 | 2 | PF00638 | |
| Domain | GRIP_dom | 5.51e-04 | 12 | 55 | 2 | IPR000237 | |
| Domain | GRIP | 5.51e-04 | 12 | 55 | 2 | PS50913 | |
| Domain | RANBD1 | 5.51e-04 | 12 | 55 | 2 | PS50196 | |
| Domain | RanBD | 6.50e-04 | 13 | 55 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 6.50e-04 | 13 | 55 | 2 | IPR000156 | |
| Domain | Ion_trans_dom | 4.61e-03 | 114 | 55 | 3 | IPR005821 | |
| Domain | Ion_trans | 4.61e-03 | 114 | 55 | 3 | PF00520 | |
| Domain | C2 | 7.67e-03 | 137 | 55 | 3 | SM00239 | |
| Domain | TF_fork_head_CS_2 | 8.11e-03 | 46 | 55 | 2 | IPR030456 | |
| Domain | PH_dom-like | 8.23e-03 | 426 | 55 | 5 | IPR011993 | |
| Domain | TF_fork_head_CS_1 | 8.46e-03 | 47 | 55 | 2 | IPR018122 | |
| Domain | C2 | 8.46e-03 | 142 | 55 | 3 | PS50004 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 4.52e-06 | 36 | 44 | 4 | M271 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 6.12e-06 | 12 | 44 | 3 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 6.12e-06 | 12 | 44 | 3 | M27939 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 1.87e-05 | 17 | 44 | 3 | M27946 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 2.65e-05 | 19 | 44 | 3 | M41732 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 4.19e-05 | 22 | 44 | 3 | MM15656 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 5.17e-05 | 66 | 44 | 4 | M27938 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 8.80e-05 | 28 | 44 | 3 | M41724 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 1.32e-04 | 32 | 44 | 3 | M39445 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.42e-04 | 6 | 44 | 2 | MM15660 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.73e-04 | 35 | 44 | 3 | M249 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 1.98e-04 | 7 | 44 | 2 | MM15661 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 1.98e-04 | 7 | 44 | 2 | M19489 | |
| Pathway | REACTOME_FLT3_SIGNALING | 2.22e-04 | 38 | 44 | 3 | M29803 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 2.63e-04 | 8 | 44 | 2 | M27919 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE | 3.21e-04 | 43 | 44 | 3 | M27534 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 3.21e-04 | 43 | 44 | 3 | MM15864 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 3.38e-04 | 9 | 44 | 2 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 3.38e-04 | 9 | 44 | 2 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 3.38e-04 | 9 | 44 | 2 | M27904 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 4.22e-04 | 10 | 44 | 2 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 4.22e-04 | 10 | 44 | 2 | MM14778 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 4.22e-04 | 10 | 44 | 2 | M27945 | |
| Pathway | PID_FOXO_PATHWAY | 4.73e-04 | 49 | 44 | 3 | M136 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 5.14e-04 | 11 | 44 | 2 | M27740 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 5.14e-04 | 11 | 44 | 2 | M27535 | |
| Pathway | WP_NAD_METABOLISM_SIRTUINS_AND_AGING | 5.14e-04 | 11 | 44 | 2 | M39439 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 5.14e-04 | 11 | 44 | 2 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 5.14e-04 | 11 | 44 | 2 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 5.14e-04 | 11 | 44 | 2 | M47432 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 5.14e-04 | 11 | 44 | 2 | M27911 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 5.32e-04 | 51 | 44 | 3 | M7955 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 5.33e-04 | 464 | 44 | 7 | M27547 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 5.64e-04 | 52 | 44 | 3 | M19877 | |
| Pathway | PID_CD8_TCR_PATHWAY | 5.96e-04 | 53 | 44 | 3 | M88 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 6.16e-04 | 12 | 44 | 2 | M29851 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 6.30e-04 | 54 | 44 | 3 | M19818 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 7.27e-04 | 13 | 44 | 2 | M47594 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 8.46e-04 | 14 | 44 | 2 | M569 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M47488 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 8.46e-04 | 14 | 44 | 2 | M27908 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 8.46e-04 | 14 | 44 | 2 | M719 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 9.74e-04 | 15 | 44 | 2 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M47531 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.89e-04 | 63 | 44 | 3 | M11187 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 9.89e-04 | 63 | 44 | 3 | M635 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 9.89e-04 | 63 | 44 | 3 | M39623 | |
| Pathway | PID_TCR_PATHWAY | 1.03e-03 | 64 | 44 | 3 | M34 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47804 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 1.11e-03 | 16 | 44 | 2 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 1.11e-03 | 16 | 44 | 2 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47483 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.11e-03 | 16 | 44 | 2 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47682 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.11e-03 | 16 | 44 | 2 | M27940 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 1.18e-03 | 67 | 44 | 3 | M295 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 1.23e-03 | 68 | 44 | 3 | M39456 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.26e-03 | 17 | 44 | 2 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 1.26e-03 | 17 | 44 | 2 | M47684 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 1.26e-03 | 17 | 44 | 2 | M27918 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 1.41e-03 | 18 | 44 | 2 | M27518 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.41e-03 | 18 | 44 | 2 | M657 | |
| Pathway | BIOCARTA_PTEN_PATHWAY | 1.41e-03 | 18 | 44 | 2 | M10145 | |
| Pathway | BIOCARTA_PTEN_PATHWAY | 1.41e-03 | 18 | 44 | 2 | MM1461 | |
| Pathway | REACTOME_TIE2_SIGNALING | 1.41e-03 | 18 | 44 | 2 | M11932 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 1.46e-03 | 72 | 44 | 3 | M39738 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2 | 1.52e-03 | 73 | 44 | 3 | M27531 | |
| Pathway | WP_INSULIN_SIGNALING | 1.52e-03 | 160 | 44 | 4 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 1.52e-03 | 160 | 44 | 4 | M39482 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 1.57e-03 | 19 | 44 | 2 | M559 | |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.64e-03 | 75 | 44 | 3 | M5436 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 1.75e-03 | 20 | 44 | 2 | M12256 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 1.75e-03 | 20 | 44 | 2 | M27519 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 1.75e-03 | 20 | 44 | 2 | M27524 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE | 1.75e-03 | 20 | 44 | 2 | M29849 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | CACNA1E ARID4B INPP4A POLR2A SPTBN1 TRMT1L FCHO2 CFB DNMT1 SFN | 5.97e-09 | 475 | 58 | 10 | 31040226 |
| Pubmed | 4.39e-08 | 5 | 58 | 3 | 18599511 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.34e-06 | 332 | 58 | 7 | 32786267 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24895270 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24448243 | ||
| Pubmed | Reduced FOXO1 expression accelerates skin wound healing and attenuates scarring. | 2.73e-06 | 2 | 58 | 2 | 25010393 | |
| Pubmed | Dysregulated FOXO transcription factors in articular cartilage in aging and osteoarthritis. | 2.73e-06 | 2 | 58 | 2 | 24269635 | |
| Pubmed | Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. | 2.73e-06 | 2 | 58 | 2 | 16952979 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 16709600 | ||
| Pubmed | Foxo in T Cells Regulates Thermogenic Program through Ccr4/Ccl22 Axis. | 2.73e-06 | 2 | 58 | 2 | 31756626 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15069012 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 27936162 | ||
| Pubmed | Lower FOXO3 mRNA expression in granulosa cells is involved in unexplained infertility. | 2.73e-06 | 2 | 58 | 2 | 28621049 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 28430387 | ||
| Pubmed | [Analysis of FOXO1A and FOXO3A Gene Allele Association with Human Longevity]. | 2.73e-06 | 2 | 58 | 2 | 27529982 | |
| Pubmed | Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia. | 2.73e-06 | 2 | 58 | 2 | 34002029 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 25952685 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 32332845 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 30511639 | ||
| Pubmed | 14-3-3sigma regulates B-cell homeostasis through stabilization of FOXO1. | 2.73e-06 | 2 | 58 | 2 | 21205887 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 20142102 | ||
| Pubmed | Foxo transcription factors control regulatory T cell development and function. | 2.73e-06 | 2 | 58 | 2 | 21167754 | |
| Pubmed | Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations. | 2.73e-06 | 2 | 58 | 2 | 19793722 | |
| Pubmed | P. gingivalis modulates keratinocytes through FOXO transcription factors. | 2.73e-06 | 2 | 58 | 2 | 24265696 | |
| Pubmed | Forkhead box class O transcription factors in liver function and disease. | 2.73e-06 | 2 | 58 | 2 | 23855308 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 21565617 | ||
| Pubmed | Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis. | 2.73e-06 | 2 | 58 | 2 | 31296961 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 36790598 | ||
| Pubmed | FoxO transcription factors support oxidative stress resistance in human chondrocytes. | 2.73e-06 | 2 | 58 | 2 | 25186470 | |
| Pubmed | FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. | 2.73e-06 | 2 | 58 | 2 | 21159781 | |
| Pubmed | FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. | 2.73e-06 | 2 | 58 | 2 | 17254970 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22406677 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22552808 | ||
| Pubmed | Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. | 2.73e-06 | 2 | 58 | 2 | 16979636 | |
| Pubmed | FOXO1 and FOXO3 Cooperatively Regulate Innate Lymphoid Cell Development. | 2.73e-06 | 2 | 58 | 2 | 35757763 | |
| Pubmed | Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. | 2.73e-06 | 2 | 58 | 2 | 16100571 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22515357 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 33325305 | ||
| Pubmed | Kinetics of nuclear-cytoplasmic translocation of Foxo1 and Foxo3A in adult skeletal muscle fibers. | 2.73e-06 | 2 | 58 | 2 | 22932683 | |
| Pubmed | Association study to evaluate FoxO1 and FoxO3 gene in CHD in Han Chinese. | 2.73e-06 | 2 | 58 | 2 | 24489705 | |
| Pubmed | FOXOs in the impaired heart: New therapeutic targets for cardiac diseases. | 2.73e-06 | 2 | 58 | 2 | 27890702 | |
| Pubmed | Effects of FOXO genotypes on longevity: a biodemographic analysis. | 2.73e-06 | 2 | 58 | 2 | 20884733 | |
| Pubmed | FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway. | 2.73e-06 | 2 | 58 | 2 | 22931788 | |
| Pubmed | Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation. | 2.73e-06 | 2 | 58 | 2 | 18823877 | |
| Pubmed | Different roles of Foxo1 and Foxo3 in the control of endothelial cell morphology. | 2.73e-06 | 2 | 58 | 2 | 19747349 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22634725 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.75e-06 | 370 | 58 | 7 | 22922362 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DSG3 SPTBN1 GARS1 PKP2 MYO1B TRMT1L NUP153 DNMT1 SFN VDAC3 KIF2C | 6.30e-06 | 1257 | 58 | 11 | 36526897 |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25576059 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 27235148 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 21730069 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18032526 | ||
| Pubmed | FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. | 8.19e-06 | 3 | 58 | 2 | 12857750 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16133873 | ||
| Pubmed | FoxO transcription factors 1 regulate mouse preimplantation embryo development. | 8.19e-06 | 3 | 58 | 2 | 31396850 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25929834 | ||
| Pubmed | Functional regulation of FoxO1 in neural stem cell differentiation. | 8.19e-06 | 3 | 58 | 2 | 26470727 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 27491024 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 21177856 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18272820 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 31767172 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22102632 | ||
| Pubmed | Forkhead BoxO transcription factors restrain exercise-induced angiogenesis. | 8.19e-06 | 3 | 58 | 2 | 25063823 | |
| Pubmed | Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis. | 8.19e-06 | 3 | 58 | 2 | 29844066 | |
| Pubmed | FOXOs attenuate bone formation by suppressing Wnt signaling. | 8.19e-06 | 3 | 58 | 2 | 23867625 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18022395 | ||
| Pubmed | Forkhead box O transcription factors in chondrocytes regulate endochondral bone formation. | 8.19e-06 | 3 | 58 | 2 | 26232637 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26917725 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24123662 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24003218 | ||
| Pubmed | Zebularine upregulates expression of CYP genes through inhibition of DNMT1 and PKR in HepG2 cells. | 8.19e-06 | 3 | 58 | 2 | 28112215 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 20142101 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24015318 | ||
| Pubmed | FoxO1 Is a Novel Regulator of 20S Proteasome Subunits Expression and Activity. | 8.19e-06 | 3 | 58 | 2 | 33634126 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22761423 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22159921 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 32847377 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 21613825 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 38622665 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19671690 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24028821 | ||
| Pubmed | Lipid availability determines fate of skeletal progenitor cells via SOX9. | 8.19e-06 | 3 | 58 | 2 | 32103177 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26929388 | ||
| Pubmed | FOXO transcription factors protect against the diet-induced fatty liver disease. | 8.19e-06 | 3 | 58 | 2 | 28300161 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25378413 | ||
| Pubmed | FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. | 8.19e-06 | 3 | 58 | 2 | 17254969 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 9153302 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26414399 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 10880363 | ||
| Pubmed | CTCF regulates the FoxO signaling pathway to affect the progression of prostate cancer. | 8.19e-06 | 3 | 58 | 2 | 30873749 | |
| Pubmed | Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity. | 8.19e-06 | 3 | 58 | 2 | 15837797 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25307742 | ||
| Pubmed | Dysregulation of FOXO transcription factors in Epstein-Barr virus-associated gastric carcinoma. | 8.19e-06 | 3 | 58 | 2 | 31712122 | |
| Pubmed | Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival. | 8.19e-06 | 3 | 58 | 2 | 24043312 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 33577435 | ||
| Pubmed | Unique dependence on Sos1 in Kras G12D -induced leukemogenesis. | 8.19e-06 | 3 | 58 | 2 | 30377195 | |
| Pubmed | Polymorphisms in FOXO gene family and association analysis with BMI. | 8.19e-06 | 3 | 58 | 2 | 16571842 | |
| Pubmed | Regulation of CHMP4/ESCRT-III function in human immunodeficiency virus type 1 budding by CC2D1A. | 8.19e-06 | 3 | 58 | 2 | 22258254 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 29900561 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24140020 | ||
| Interaction | SIRT6 interactions | FOXO3 FAT1 LRCH2 RGPD8 POLR2A TMEM209 PKP2 TRMT1L NUP153 RGPD5 | 1.09e-05 | 628 | 58 | 10 | int:SIRT6 |
| Interaction | MAPRE1 interactions | 1.49e-05 | 514 | 58 | 9 | int:MAPRE1 | |
| Interaction | NPIPB6 interactions | 1.79e-05 | 18 | 58 | 3 | int:NPIPB6 | |
| Interaction | CD2AP interactions | 3.41e-05 | 214 | 58 | 6 | int:CD2AP | |
| Interaction | ROR2 interactions | 4.61e-05 | 333 | 58 | 7 | int:ROR2 | |
| Interaction | HDAC4 interactions | CACNA1E ARID4B INPP4A POLR2A SPTBN1 GARS1 TRMT1L FCHO2 DNMT1 SFN | 4.64e-05 | 744 | 58 | 10 | int:HDAC4 |
| Interaction | SLC26A8 interactions | 4.87e-05 | 4 | 58 | 2 | int:SLC26A8 | |
| Interaction | CDKL2 interactions | 5.20e-05 | 71 | 58 | 4 | int:CDKL2 | |
| Interaction | PLCH1 interactions | 6.12e-05 | 74 | 58 | 4 | int:PLCH1 | |
| Interaction | TBCK interactions | 9.14e-05 | 82 | 58 | 4 | int:TBCK | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.15e-06 | 144 | 57 | 5 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 4.94e-06 | 194 | 57 | 5 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 4.94e-06 | 194 | 57 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.59e-06 | 199 | 57 | 5 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.71e-05 | 135 | 57 | 4 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.53e-05 | 154 | 57 | 4 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 7.27e-05 | 174 | 57 | 4 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | Control-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 7.77e-05 | 177 | 57 | 4 | e82115bfc32c7b689460fbc5caeb983c1aabe30f | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.94e-05 | 178 | 57 | 4 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.94e-05 | 178 | 57 | 4 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 8.12e-05 | 179 | 57 | 4 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 8.29e-05 | 180 | 57 | 4 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|CF / Disease state, Lineage and Cell class | 8.66e-05 | 182 | 57 | 4 | a8dfc59a3974e3433f434676b7c2749d0fcfc8b2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 9.03e-05 | 184 | 57 | 4 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.41e-05 | 186 | 57 | 4 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.41e-05 | 186 | 57 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.61e-05 | 187 | 57 | 4 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.61e-05 | 187 | 57 | 4 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.61e-05 | 187 | 57 | 4 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.81e-05 | 188 | 57 | 4 | 2b8d70f761eda5509f21845a87cdb3602a639dd7 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-04 | 189 | 57 | 4 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.00e-04 | 189 | 57 | 4 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-04 | 189 | 57 | 4 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-04 | 190 | 57 | 4 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 191 | 57 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 192 | 57 | 4 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.06e-04 | 192 | 57 | 4 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 192 | 57 | 4 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | wk_15-18|World / Celltypes from embryonic and fetal-stage human lung | 1.09e-04 | 193 | 57 | 4 | a28ff1e80e3e741739abe869df5fbd41352a1ea0 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 194 | 57 | 4 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.11e-04 | 194 | 57 | 4 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.11e-04 | 194 | 57 | 4 | 784b15119c91ace33d34bfb3d68c182566a3e9a8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 195 | 57 | 4 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 195 | 57 | 4 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-04 | 195 | 57 | 4 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 195 | 57 | 4 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 1.15e-04 | 196 | 57 | 4 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 196 | 57 | 4 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 196 | 57 | 4 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 196 | 57 | 4 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.17e-04 | 197 | 57 | 4 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 197 | 57 | 4 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 197 | 57 | 4 | c9c968e223e7814cd8d22975d849a31b7e0af7aa | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-04 | 197 | 57 | 4 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.17e-04 | 197 | 57 | 4 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 197 | 57 | 4 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 197 | 57 | 4 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 197 | 57 | 4 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-04 | 197 | 57 | 4 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-04 | 197 | 57 | 4 | da653dc7d216e202f390e5ab0245f243e3ed213b | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.17e-04 | 197 | 57 | 4 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 197 | 57 | 4 | e344455e62b3fe94bb242dc0db58d19a1d3878c7 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.17e-04 | 197 | 57 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 198 | 57 | 4 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | distal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-04 | 198 | 57 | 4 | ce05ede69c167b2294630709bb0c223483a6ef75 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-04 | 198 | 57 | 4 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.22e-04 | 199 | 57 | 4 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 1.22e-04 | 199 | 57 | 4 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.22e-04 | 199 | 57 | 4 | 6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 200 | 57 | 4 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 200 | 57 | 4 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 200 | 57 | 4 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-04 | 200 | 57 | 4 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Cortical_neuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 200 | 57 | 4 | 458fb0f40c1720f1cacedf78c40bd059692bfc62 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 200 | 57 | 4 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Hist1h2al))|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.59e-04 | 82 | 57 | 3 | 3cee9ee752128dd91e9abc05c9f97b17e64a2a76 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-04 | 114 | 57 | 3 | 670c9802a59b39241abf6f2c12a3d1844c7db5e5 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-04 | 118 | 57 | 3 | 04355cac58ec046730365d6649aa1e31396901c3 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 4.87e-04 | 120 | 57 | 3 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.99e-04 | 121 | 57 | 3 | 2ae870f822488799cd0ad85e7f72af64e33a867f | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.63e-04 | 140 | 57 | 3 | a8f3b01d03ee0bf0e752327a98d6b9035930c2b0 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.79e-04 | 141 | 57 | 3 | 1e01cfbfbe7d5a6fdaf74c78f286f62ea7898e2d | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.79e-04 | 147 | 57 | 3 | 3ed5b020ce1f1277917d79ef1f7da53fa474e8db | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.96e-04 | 148 | 57 | 3 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | Dividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.96e-04 | 148 | 57 | 3 | 66b51aa6690bf8fbc90fa5a6f86191703e2d5046 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 1.04e-03 | 156 | 57 | 3 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 158 | 57 | 3 | 66c011e9de002224f70725dfe8e7871c8d304492 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 160 | 57 | 3 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-03 | 161 | 57 | 3 | 78cb72c462167021195917a06052bcdc367ad890 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-03 | 161 | 57 | 3 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-03 | 161 | 57 | 3 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.14e-03 | 161 | 57 | 3 | 7e0b8119cea208c0b4a0dffdf94ff6137d0b4c90 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-03 | 161 | 57 | 3 | 06e7becfd11d6ef1a45a9cfdfcb40b812600038e | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-03 | 161 | 57 | 3 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-03 | 163 | 57 | 3 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-03 | 164 | 57 | 3 | e86899aa68aac572009618c7e017e6734b86357c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-03 | 165 | 57 | 3 | 4d364e1aae41aea483d1311e5e8ef4fc33e30d5e | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-03 | 166 | 57 | 3 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-03 | 166 | 57 | 3 | 3e3e9296e6919a38602e417a6606c046af3bd101 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 1.25e-03 | 166 | 57 | 3 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-03 | 167 | 57 | 3 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-03 | 167 | 57 | 3 | 3c3e1c31aacca48099693aea2efdfa22fc0e4af4 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-03 | 167 | 57 | 3 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-03 | 167 | 57 | 3 | 77a4d7ce44847c76074d4f5340d61b398fe43e6c | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-03 | 168 | 57 | 3 | 95416f352801ce42cc317565e7dfb00478c593e1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-03 | 168 | 57 | 3 | 29a6c3ba69e03ccb19efb8ac177b9a162dc1ea43 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-03 | 168 | 57 | 3 | 4297be958a4754677df7cf73feba19b0d76f1b4a | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.31e-03 | 169 | 57 | 3 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-03 | 169 | 57 | 3 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-03 | 169 | 57 | 3 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| Drug | procyanidin B2 | 1.47e-06 | 33 | 58 | 4 | ctd:C479580 | |
| Disease | prostate cancer (is_marker_for) | 5.18e-07 | 156 | 56 | 6 | DOID:10283 (is_marker_for) | |
| Disease | aortic disease (biomarker_via_orthology) | 3.54e-06 | 2 | 56 | 2 | DOID:520 (biomarker_via_orthology) | |
| Disease | cerebral infarction (is_marker_for) | 6.14e-06 | 19 | 56 | 3 | DOID:3526 (is_marker_for) | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 1.09e-05 | 72 | 56 | 4 | DOID:9744 (is_marker_for) | |
| Disease | thromboangiitis obliterans (biomarker_via_orthology) | 3.52e-05 | 5 | 56 | 2 | DOID:12918 (biomarker_via_orthology) | |
| Disease | Myelomonocytic leukemia | 3.52e-05 | 5 | 56 | 2 | C0027019 | |
| Disease | Cardiomyopathies | 1.11e-04 | 130 | 56 | 4 | C0878544 | |
| Disease | diabetic retinopathy (is_implicated_in) | 1.19e-04 | 50 | 56 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | Noonan syndrome | 1.26e-04 | 9 | 56 | 2 | cv:C0028326 | |
| Disease | beta thalassemia (is_marker_for) | 1.92e-04 | 11 | 56 | 2 | DOID:12241 (is_marker_for) | |
| Disease | Turner Syndrome, Male | 1.92e-04 | 11 | 56 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.92e-04 | 11 | 56 | 2 | C1527404 | |
| Disease | Noonan Syndrome 1 | 1.92e-04 | 11 | 56 | 2 | C4551602 | |
| Disease | rheumatoid arthritis (is_marker_for) | 3.10e-04 | 69 | 56 | 3 | DOID:7148 (is_marker_for) | |
| Disease | RASopathy | 3.66e-04 | 15 | 56 | 2 | cv:C5555857 | |
| Disease | sickle cell anemia (is_implicated_in) | 4.17e-04 | 16 | 56 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | lupus nephritis (is_marker_for) | 4.72e-04 | 17 | 56 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | carotid artery disease (is_marker_for) | 5.93e-04 | 19 | 56 | 2 | DOID:3407 (is_marker_for) | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 5.93e-04 | 19 | 56 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 5.93e-04 | 19 | 56 | 2 | C0587248 | |
| Disease | Juvenile Myelomonocytic Leukemia | 5.93e-04 | 19 | 56 | 2 | C0349639 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 5.93e-04 | 19 | 56 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 5.93e-04 | 19 | 56 | 2 | C1275081 | |
| Disease | Adenocarcinoma of lung (disorder) | 6.38e-04 | 206 | 56 | 4 | C0152013 | |
| Disease | chronic kidney disease (is_marker_for) | 6.58e-04 | 20 | 56 | 2 | DOID:784 (is_marker_for) | |
| Disease | corneal hysteresis | 6.58e-04 | 20 | 56 | 2 | EFO_0010066 | |
| Disease | periodontitis (biomarker_via_orthology) | 7.26e-04 | 21 | 56 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | LEOPARD Syndrome | 7.98e-04 | 22 | 56 | 2 | C0175704 | |
| Disease | Adenoid Cystic Carcinoma | 9.19e-04 | 100 | 56 | 3 | C0010606 | |
| Disease | Noonan Syndrome | 9.51e-04 | 24 | 56 | 2 | C0028326 | |
| Disease | Weight Gain | 9.73e-04 | 102 | 56 | 3 | C0043094 | |
| Disease | pneumonia, COVID-19 | 1.31e-03 | 113 | 56 | 3 | EFO_0003106, MONDO_0100096 | |
| Disease | Myeloid Leukemia, Chronic | 1.39e-03 | 29 | 56 | 2 | C0023473 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGYQMSFDTAKSKLS | 151 | Q9Y277 | |
| RGKNQKMYEASIKDS | 581 | Q4LE39 | |
| AAAYKQTKAQRARTM | 36 | Q15878 | |
| GMNRFNSRTYSKFKN | 1231 | P26358 | |
| GMSSISDYKKNVQSQ | 951 | Q8WWZ4 | |
| SARSAYQEAMDISKK | 146 | P31947 | |
| RSMTKLAKSASNYSQ | 51 | Q0JRZ9 | |
| TNTEVLKNMGYAAKA | 101 | Q9H444 | |
| RGAGKMNQVTSKYAN | 1351 | Q9P241 | |
| AMNRNGKETKSNYRV | 101 | Q15109 | |
| YRMKKLNSSDDGTQG | 166 | P01111 | |
| KLFSSRYGKMANKAN | 1001 | Q99666 | |
| RYGKMANKANTSGDF | 1006 | Q99666 | |
| KLFSSRYGKMANKAN | 1001 | O14715 | |
| RYGKMANKANTSGDF | 1006 | O14715 | |
| RASKAAAGKMNLYES | 696 | Q68E01 | |
| EDGTSSYKDFAMSKN | 421 | Q8WVV9 | |
| SYKDFAMSKNNRFTS | 426 | Q8WVV9 | |
| NTMKNVGSRKYAFNS | 941 | Q96PE3 | |
| EYMCKAVNNKGSAAS | 651 | Q0ZGT2 | |
| SGTNTKKALQAVYSM | 351 | P00751 | |
| TNKAASNVKYVMGRN | 416 | P32926 | |
| KFSMDYKTGALTVQN | 1926 | Q14517 | |
| AYTAKMAAANGSKKA | 381 | P57723 | |
| YRNGQVEMSSDKQAK | 131 | Q6TGC4 | |
| AKSGSANAYMQSKRN | 436 | Q9NZV8 | |
| EKRMYSKSRDHNSSN | 661 | Q13427 | |
| TEMNKGKSRNYSNSK | 196 | A2PYH4 | |
| ASSKSEKNEYAFMGA | 191 | Q6P988 | |
| GAKQTEATMTFKYNR | 1041 | P04114 | |
| SMDNNSKFAKSRSRA | 256 | Q12778 | |
| MERYQVAAAQAKSKG | 356 | Q6P1N0 | |
| TNYRKSVMSLAEAGK | 241 | P22676 | |
| ALRDNSTTGYMAAKK | 306 | Q58FG1 | |
| TGDSNRTKYMAQIQK | 4621 | Q8NDH2 | |
| AQNASKGIYAMASRD | 366 | Q99661 | |
| QFVSRSENKYKRMNS | 901 | Q9BXL7 | |
| YKSMRKSSSGNENDE | 566 | Q5VUJ6 | |
| AVSMDNSNKYTKSRG | 251 | O43524 | |
| HMNKGETKSSYIAAS | 206 | Q7Z2T5 | |
| TDNYIAQGKRKSNEM | 601 | Q7Z2T5 | |
| STRKNSQDKIYNSYM | 66 | Q8NB59 | |
| RKANMKGSYSLVEAQ | 721 | P19320 | |
| ETDKNDNSRYKMSSS | 821 | Q96RN1 | |
| SNMTVIYFKSDGKNR | 506 | Q7RTY7 | |
| YSAKAQVSGQSARKM | 376 | P41250 | |
| YSRTMAKSSVDQKDG | 31 | A0A096LP01 | |
| QMGSYSNNSTEKKFL | 601 | Q7Z745 | |
| SESACRFYSQQMKGK | 401 | Q07889 | |
| NQEMGFYKDAKTAAS | 2231 | Q01082 | |
| NRKRKGSSTDYQESM | 36 | O00327 | |
| NYDAASGTMRKSQAK | 31 | Q96S66 | |
| YTMGLKNARNNKSEE | 236 | Q8IX90 | |
| EQKKYNSQGTSTDML | 386 | Q6ZVD7 | |
| SEYNNFKSMVVSGAK | 761 | P24928 | |
| MKAKQLSAQSYGVTS | 291 | P49790 | |
| SRSMGDYAQTLKKFQ | 276 | Q96SK2 | |
| AFKMNRKERSSYDSS | 1316 | Q9Y6X0 | |
| SAKQNYKNYSMESRT | 571 | Q5SRH9 | |
| KIMAISAGDAYASNK | 821 | Q99959 | |
| SKFKKTRYQAGMRNS | 751 | Q9HCX4 | |
| MAAGETQLYAKVSNK | 1 | P57075 | |
| KTVRNDNSSRFGKYM | 156 | O43795 |